| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
A2a Pharmaceuticals, Inc. is a 10% Owner at Biomea Fusion, Inc.. Recent SEC Form 4 filings include 2 buys and 9 sells.
Estimated insider holdings value: $5.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2023 | BMEA Biomea Fusion, Inc. | 10% Owner | Sell | 125,000 | $34.11 | $4,263,915.00 | -1.7% | -53.6% | -70.5% | |
| May 12, 2023 | BMEA Biomea Fusion, Inc. | 10% Owner | Sell | 25,000 | $33.84 | $846,000.00 | -0.7% | -45.4% | -68.7% | |
| May 9, 2023 | BMEA Biomea Fusion, Inc. | 10% Owner | Sell | 250,000 | $34.30 | $8,575,030.00 | -3.2% | -45.8% | -67.2% | |
| Apr 20, 2023 | BMEA Biomea Fusion, Inc. | 10% Owner | Sell | 200,000 | $29.12 | $5,823,760.00 | -4.9% | -27.0% | -62.9% | |
| Mar 31, 2023 | BMEA Biomea Fusion, Inc. | 10% Owner | Sell | 200,000 | $31.25 | $6,250,000.00 | -4.7% | -30.2% | -50.7% | |
| Aug 16, 2022 | BMEA Biomea Fusion, Inc. | 10% Owner | Buy | 30,684 | $13.87 | $425,648.45 | +0.7% | -41.4% | +24.3% | |
| Jul 21, 2022 | BMEA Biomea Fusion, Inc. | 10% Owner | Sell | 34,658 | $11.21 | $388,516.18 | -0.8% | -24.0% | +81.7% | |
| Jun 24, 2022 | BMEA Biomea Fusion, Inc. | 10% Owner | Sell | 34,658 | $11.76 | $407,578.08 | -0.8% | -7.9% | +156.7% | |
| Sep 17, 2021 | BMEA Biomea Fusion, Inc. | 10% Owner | Buy | 34,658 | $10.96 | $379,851.68 | +0.8% | -30.4% | +5.9% |